March 31, 2015March 31, 2015

Biodesix’s Lung Cancer Test Shown To Decrease Drug Costs

Lung Cancer, News

A novel lung cancer test called Veristrat developed by Biodesix may help decrease expenses in lung cancer-related treatments in lifetime direct medical cost per patient. The conclusions are from a health-related economic study supported by the ... Read more

March 17, 2015March 17, 2015

Biodesix and Inivata Partner Against Lung Cancer Through Development of TAm-Seq™ Technology Platform

Lung Cancer, News

Biodesix, Inc. and Inivata recently announced a partnership to advance and commercialize Next Generation Sequencing (NGS) tests (blood tests) that might have clinical applications for lung cancer. This agreement will help further develop the TAm-Seq™ technology ... Read more